BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20308725)

  • 1. Hepatoblastoma. Clinical experience at a single institution using the Siopel staging system.
    Leal-Leal CA; Imaz-Olguín V; Robles-Castro J; Shalkow-Klincovstein J; Palacios-Acosta JM
    Ann Hepatol; 2010; 9(1):75-9. PubMed ID: 20308725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study.
    Aronson DC; Schnater JM; Staalman CR; Weverling GJ; Plaschkes J; Perilongo G; Brown J; Phillips A; Otte JB; Czauderna P; MacKinlay G; Vos A
    J Clin Oncol; 2005 Feb; 23(6):1245-52. PubMed ID: 15718322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.
    Meyers RL; Rowland JR; Krailo M; Chen Z; Katzenstein HM; Malogolowkin MH
    Pediatr Blood Cancer; 2009 Dec; 53(6):1016-22. PubMed ID: 19588519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment strategy for advanced hepatoblastoma: Resection versus transplantation.
    Uchida H; Sakamoto S; Sasaki K; Takeda M; Hirata Y; Fukuda A; Hishiki T; Irie R; Nakazawa A; Miyazaki O; Nosaka S; Kasahara M
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27383. PubMed ID: 30084209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
    Liu APY; Ip JJK; Leung AWK; Luk CW; Li CH; Ho KKH; Lo R; Chan EKW; Chan ACY; Chung PHY; Chiang AKS
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen--a report from the study group for pediatric solid malignant tumors in the Kyushu area.
    Suita S; Tajiri T; Takamatsu H; Mizote H; Nagasaki A; Inomata Y; Hara T; Okamura J; Miyazaki S; Kawakami K; Eguchi H; Tsuneyoshi M;
    J Pediatr Surg; 2004 Feb; 39(2):195-8; discussion 195-8. PubMed ID: 14966739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
    Meyers RL; Maibach R; Hiyama E; Häberle B; Krailo M; Rangaswami A; Aronson DC; Malogolowkin MH; Perilongo G; von Schweinitz D; Ansari M; Lopez-Terrada D; Tanaka Y; Alaggio R; Leuschner I; Hishiki T; Schmid I; Watanabe K; Yoshimura K; Feng Y; Rinaldi E; Saraceno D; Derosa M; Czauderna P
    Lancet Oncol; 2017 Jan; 18(1):122-131. PubMed ID: 27884679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of survival after resection of children with hepatoblastoma: A single Asian center experience.
    Qiao GL; Li L; Cheng W; Ge J; Zhang Z; Wei Y
    Eur J Surg Oncol; 2014 Nov; 40(11):1533-9. PubMed ID: 25103357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor.
    Sasaki F; Matsunaga T; Iwafuchi M; Hayashi Y; Ohkawa H; Ohira M; Okamatsu T; Sugito T; Tsuchida Y; Toyosaka A; Nagahara N; Nishihira H; Hata Y; Uchino J; Misugi K; Ohnuma N;
    J Pediatr Surg; 2002 Jun; 37(6):851-6. PubMed ID: 12037748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidisciplinary management of hepatoblastoma in children: Experience from a developing country.
    Shanmugam N; Scott JX; Kumar V; Vij M; Ramachandran P; Narasimhan G; Reddy MS; Kota V; Munirathnam D; Kelgeri C; Sundaram K; Rela M
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27781375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of neoadjuvant therapy and surgical rescue for locally advanced hepatoblastomas: 10 year single-center experience and literature review.
    Ayllon Teran D; Gómez Beltran O; Ciria Bru R; Mateos González E; Peña Rosa MJ; Luque Molina A; López Cillero P; Briceño Delgado J
    World J Gastroenterol; 2014 Aug; 20(29):10137-43. PubMed ID: 25110441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical strategies for unresectable hepatoblastomas.
    Tajiri T; Kimura O; Fumino S; Furukawa T; Iehara T; Souzaki R; Kinoshita Y; Koga Y; Suminoe A; Hara T; Kohashi K; Oda Y; Hishiki T; Hosoi H; Hiyama E; Taguchi T
    J Pediatr Surg; 2012 Dec; 47(12):2194-8. PubMed ID: 23217875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and prognostic factors of hepatoblastoma in 316 children aged under 3 years - a 14-year retrospective single-center study.
    Zhi T; Zhang WL; Zhang Y; Hu HM; Huang DS
    BMC Pediatr; 2021 Apr; 21(1):170. PubMed ID: 33849474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL).
    Semeraro M; Branchereau S; Maibach R; Zsiros J; Casanova M; Brock P; Domerg C; Aronson DC; Zimmermann A; Laithier V; Childs M; Roebuck D; Perilongo G; Czauderna P; Brugieres L
    Eur J Cancer; 2013 Mar; 49(4):915-22. PubMed ID: 23146961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma--a report from the German Cooperative Pediatric Liver Tumor Study HB-89.
    von Schweinitz D; Hecker H; Harms D; Bode U; Weinel P; Bürger D; Erttmann R; Mildenberger H
    J Pediatr Surg; 1995 Jun; 30(6):845-52. PubMed ID: 7545228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of postoperative complications on overall survival of patients with hepatoblastoma.
    Becker K; Furch C; Schmid I; von Schweinitz D; Häberle B
    Pediatr Blood Cancer; 2015 Jan; 62(1):24-8. PubMed ID: 25251521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical Resection for Hepatoblastoma-Updated Survival Outcomes.
    Sunil BJ; Palaniappan R; Venkitaraman B; Ranganathan R
    J Gastrointest Cancer; 2018 Dec; 49(4):493-496. PubMed ID: 28963691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT).
    Towbin AJ; Meyers RL; Woodley H; Miyazaki O; Weldon CB; Morland B; Hiyama E; Czauderna P; Roebuck DJ; Tiao GM
    Pediatr Radiol; 2018 Apr; 48(4):536-554. PubMed ID: 29427028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan.
    Hsu WY; Chang HH; Lu MY; Yang YL; Jou ST; Chen HL; Ni YH; Hsu HY; Chang MH; Wu JF
    Pediatr Neonatol; 2020 Aug; 61(4):393-398. PubMed ID: 32291200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.